Anti-thymocyte globulin for GVHD: one dose does not fit all

doi:10.1016/S2352-3026(20)30181-2

Comment

. 2020 Jul;7(7):e505.

doi: 10.1016/S2352-3026(20)30181-2.

Anti-thymocyte globulin for GVHD: one dose does not fit all

Rick Admiraal¹, Jaap J Boelens²

Affiliations

¹ Paediatric Blood and Marrow Transplant Program, Princess Maxima Center for Pediatric Oncology, 3720 AC Bilthoven, Netherlands. Electronic address: r.admiraal-4@prinsesmaximacentrum.nl.
² Stem Cell Transplant and Cellular Therapies, Memorial Sloane Kettering Cancer Center, New York, NY, USA.

PMID: 32589973
DOI: 10.1016/S2352-3026(20)30181-2

Comment

Anti-thymocyte globulin for GVHD: one dose does not fit all

Rick Admiraal et al. Lancet Haematol. 2020 Jul.

. 2020 Jul;7(7):e505.

doi: 10.1016/S2352-3026(20)30181-2.

Authors

Rick Admiraal¹, Jaap J Boelens²

Affiliations

¹ Paediatric Blood and Marrow Transplant Program, Princess Maxima Center for Pediatric Oncology, 3720 AC Bilthoven, Netherlands. Electronic address: r.admiraal-4@prinsesmaximacentrum.nl.
² Stem Cell Transplant and Cellular Therapies, Memorial Sloane Kettering Cancer Center, New York, NY, USA.

PMID: 32589973
DOI: 10.1016/S2352-3026(20)30181-2

No abstract available

PubMed Disclaimer

Comment on

Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial.
Walker I, Panzarella T, Couban S, Couture F, Devins G, Elemary M, Gallagher G, Kerr H, Kuruvilla J, Lee SJ, Moore J, Nevill T, Popradi G, Roy J, Schultz KR, Szwajcer D, Toze C, Foley R; Cell Therapy Transplant Canada. Walker I, et al. Lancet Haematol. 2020 Feb;7(2):e100-e111. doi: 10.1016/S2352-3026(19)30220-0. Epub 2020 Jan 17. Lancet Haematol. 2020. PMID: 31958417 Clinical Trial.

Cited by

Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults.
Chakupurakal G, Freudenberger P, Skoetz N, Ahr H, Theurich S. Chakupurakal G, et al. Cochrane Database Syst Rev. 2023 Jun 21;6(6):CD009159. doi: 10.1002/14651858.CD009159.pub3. Cochrane Database Syst Rev. 2023. PMID: 37341189 Free PMC article.
Comparison of alemtuzumab, anti-thymocyte globulin, and post-transplant cyclophosphamide for graft-versus-host disease and graft-versus-leukemia in murine models.
Mashima K, Oh I, Fujiwara K, Izawa J, Takayama N, Nakano H, Kawasaki Y, Minakata D, Yamasaki R, Morita K, Ashizawa M, Yamamoto C, Hatano K, Sato K, Ohmine K, Fujiwara SI, Ohno N, Kanda Y. Mashima K, et al. PLoS One. 2021 Jan 11;16(1):e0245232. doi: 10.1371/journal.pone.0245232. eCollection 2021. PLoS One. 2021. PMID: 33428661 Free PMC article.
Hematopoietic stem cell transplantation for thalassemia major using HLA fully-matched and mismatched donor grafts.
Huang C, Qu Y, Liu S, Nie S, Jiang H. Huang C, et al. Transl Pediatr. 2021 Jun;10(6):1552-1565. doi: 10.21037/tp-20-415. Transl Pediatr. 2021. PMID: 34295770 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Anti-thymocyte globulin for GVHD: one dose does not fit all

Affiliations

Anti-thymocyte globulin for GVHD: one dose does not fit all

Authors

Affiliations

Comment on

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources